pigmented villonodular synovitis
Information
- Disease name
- pigmented villonodular synovitis
- Disease ID
- DOID:2702
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05804045 | Active, not recruiting | Phase 3 | Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) | April 27, 2023 | June 2028 |
| NCT03069469 | Active, not recruiting | Phase 1/Phase 2 | Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor | February 16, 2017 | August 2028 |
| NCT04731675 | Active, not recruiting | Phase 2 | An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee | May 25, 2021 | October 31, 2022 |
| NCT05059262 | Active, not recruiting | Phase 3 | Study of Vimseltinib for Tenosynovial Giant Cell Tumor | October 14, 2021 | July 2026 |
| NCT01207492 | Active, not recruiting | Phase 2 | Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor | September 2010 | January 2025 |
| NCT02471716 | Completed | Phase 1/Phase 2 | Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor | June 2015 | April 30, 2020 |
| NCT02371369 | Completed | Phase 3 | Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) | May 11, 2015 | April 30, 2021 |
| NCT04955535 | Completed | Screening of Specific Genes for Pigmented Villous Nodular Synovitis | August 3, 2020 | December 27, 2020 | |
| NCT04952896 | Completed | Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease | January 1, 2012 | October 29, 2022 | |
| NCT01261429 | Completed | Phase 2 | Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | December 2010 | April 2013 |
| NCT01643850 | Completed | Phase 2 | MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) | April 23, 2012 | December 21, 2018 |
| NCT05349643 | Recruiting | Phase 2 | A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT | January 26, 2023 | January 2026 |
| NCT04938180 | Terminated | Phase 2 | A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | September 16, 2021 | May 17, 2022 |
- Disase is a (Disease Ontology)
- DOID:2703
- Cross Reference ID (Disease Ontology)
- GARD:7396
- Cross Reference ID (Disease Ontology)
- ICD10CM:M12.2
- Cross Reference ID (Disease Ontology)
- MESH:D013586
- Cross Reference ID (Disease Ontology)
- NCI:C3401
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:202903009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0039106
- Exact Synonym (Disease Ontology)
- Diffuse Giant cell tumor of Tenosynovium
- Exact Synonym (Disease Ontology)
- villous tenosynovitis
- OrphaNumber from OrphaNet (Orphanet)
- 66627